Warby Parker Inc.

WRBY Healthcare Medical Instruments & Supplies

Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024. In the quarter to June 2026, revenue grew 9.81%, EPS grew 379.7% and free cash flow fell 71.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

23.40 1.19 −4.84%
Market cap
$3.0B
P/E
334×
Fwd P/E
122×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.64
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 6 6 6
ROE
0.20% 0.46% 0.37% 2.06%
ROA
0.11% 0.23% 0.19% 1.05%
ROIC
(5.53%) (4.10%) (4.38%) 0.98%
Return on Tangible Assets
0.18% 0.42% 0.34% 1.89%
Average Days of Receivables
0.49 1.38 0.72 0.83
Free Cash Flow per Share
0.31 0.36 0.32 0.18
Free Cash Flow
37.79 43.74 38.90 21.75
Other line items

Show all line items

Columns are period end dates